TNON Stock Summary and Trading Ideas (Tenon Medical | NASDAQ:TNON)

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Tenon Medical trades on the NASDAQ stock market under the symbol TNON.

As of April 7, 2026, TNON stock price declined to $0.74 with 36,966 million shares trading.

TNON has a beta of 3.12, meaning it tends to be more sensitive to market movements. TNON has a correlation of 0.31 to the broad based SPY ETF.

TNON has a market cap of $8.22 million. This is considered a Sub-Micro Cap stock.

Last quarter Tenon Medical reported $2 million in Revenue and -$.22 earnings per share. This beat revenue expectation by $121,500 and exceeded earnings estimates by $.14.

In the last 3 years, TNON traded as high as $184.00 and as low as $.64.

The top ETF exchange traded funds that TNON belongs to (by Net Assets): VXF.

TNON has underperformed the market in the last year with a price return of -38.3% while the SPY ETF gained +31.5%. TNON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.0% and -8.4%, respectively, while the SPY returned -4.7% and +0.3%, respectively.

TNON support price is $.71 and resistance is $.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNON shares will trade within this expected range on the day.